1. Home
  2. MYNZ vs SMTK Comparison

MYNZ vs SMTK Comparison

Compare MYNZ & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • SMTK
  • Stock Information
  • Founded
  • MYNZ 2021
  • SMTK 2009
  • Country
  • MYNZ Germany
  • SMTK United Kingdom
  • Employees
  • MYNZ N/A
  • SMTK N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • SMTK
  • Sector
  • MYNZ Health Care
  • SMTK
  • Exchange
  • MYNZ Nasdaq
  • SMTK NYSE
  • Market Cap
  • MYNZ 11.2M
  • SMTK 11.2M
  • IPO Year
  • MYNZ 2021
  • SMTK N/A
  • Fundamental
  • Price
  • MYNZ $3.78
  • SMTK $2.90
  • Analyst Decision
  • MYNZ Hold
  • SMTK
  • Analyst Count
  • MYNZ 2
  • SMTK 0
  • Target Price
  • MYNZ N/A
  • SMTK N/A
  • AVG Volume (30 Days)
  • MYNZ 128.8K
  • SMTK 642.0K
  • Earning Date
  • MYNZ 10-21-2024
  • SMTK 02-12-2025
  • Dividend Yield
  • MYNZ N/A
  • SMTK N/A
  • EPS Growth
  • MYNZ N/A
  • SMTK N/A
  • EPS
  • MYNZ N/A
  • SMTK N/A
  • Revenue
  • MYNZ $917,203.00
  • SMTK $40,000.00
  • Revenue This Year
  • MYNZ $36.69
  • SMTK N/A
  • Revenue Next Year
  • MYNZ $91.67
  • SMTK N/A
  • P/E Ratio
  • MYNZ N/A
  • SMTK N/A
  • Revenue Growth
  • MYNZ 16.23
  • SMTK 471.43
  • 52 Week Low
  • MYNZ $0.18
  • SMTK $2.01
  • 52 Week High
  • MYNZ $7.95
  • SMTK $13.00
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 53.35
  • SMTK N/A
  • Support Level
  • MYNZ $4.30
  • SMTK N/A
  • Resistance Level
  • MYNZ $7.95
  • SMTK N/A
  • Average True Range (ATR)
  • MYNZ 0.91
  • SMTK 0.00
  • MACD
  • MYNZ -0.15
  • SMTK 0.00
  • Stochastic Oscillator
  • MYNZ 46.33
  • SMTK 0.00

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About SMTK SMARTKEM INC

SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.

Share on Social Networks: